Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Cfa split intein is a highly efficient protein-splicing element derived from the DnaE polymerase of the bacterium Candidatus Falsirhodobacter halotolerans (Stevens, A. J., et al., 2017, JACS). It is composed of two separate polypeptides, the N-terminal (CfaN) and C-terminal (CfaC) fragments, which possess a high affinity for one another and undergo spontaneous reassembly. Once assembled, the intein catalyzes its own excision while simultaneously joining the flanking protein sequences, known as exteins, with a native peptide bond through a process called protein trans-splicing (PTS). This intein is particularly valued in biotechnology due to its exceptional splicing speed, high yields, and robustness across various temperatures and buffer conditions. It is frequently employed in synthetic biology and gene therapy to circumvent size limits of delivery vectors, such as Adeno-associated viruses (AAV), by splitting large therapeutic proteins like Cas9 into two parts that reconstitute functionally within the target cell (Li, J., et al., 2021, Communications Biology). While not a traditional drug target, its role as a molecular tool is critical for developing next-generation biologics and precision medicines.
Protein trans-splicing (PTS) involving four nucleophilic displacement steps to ligate flanking exteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candidatus Falsirhodobacter halotolerans DnaE split intein (Cfa split intein) (Cfa split intein).